Connor, Clark & Lunn Investment Management Ltd. - ARGENX SE ownership

ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 170 filers reported holding ARGENX SE in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.4%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ARGENX SE
ValueSharesWeighting
Q3 2023$223,200
-94.7%
454
-95.9%
0.00%
-95.8%
Q4 2022$4,235,319
-30.8%
11,180
-35.5%
0.02%
-40.0%
Q3 2022$6,121,000
+61.4%
17,338
+73.2%
0.04%
+73.9%
Q2 2022$3,792,000
+1289.0%
10,009
+1055.8%
0.02%
+2200.0%
Q1 2022$273,000
-33.7%
866
-26.4%
0.00%
-50.0%
Q4 2021$412,000
+6.2%
1,176
-8.6%
0.00%0.0%
Q3 2021$388,000
-35.2%
1,286
-51.6%
0.00%
-50.0%
Q2 2020$599,000
-81.2%
2,658
-90.5%
0.00%
-81.8%
Q3 2019$3,189,000
-51.9%
27,986
-40.2%
0.02%
-47.6%
Q2 2019$6,625,000
-4.6%
46,795
-15.8%
0.04%
-8.7%
Q1 2019$6,941,000
+25.9%
55,600
-3.1%
0.05%
+21.1%
Q4 2018$5,512,000
-1.3%
57,375
-22.0%
0.04%
+18.8%
Q3 2018$5,582,000
-8.5%
73,6000.0%0.03%
-5.9%
Q2 2018$6,098,000
+79.8%
73,600
+74.6%
0.03%
+61.9%
Q1 2018$3,391,000
+66.3%
42,150
+30.5%
0.02%
+75.0%
Q4 2017$2,039,00032,3000.01%
Other shareholders
ARGENX SE shareholders Q2 2020
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 285,198$106,259,07129.06%
Avoro Capital Advisors LLC 1,287,500$479,696,7507.11%
Paradigm Biocapital Advisors LP 181,172$67,501,0646.40%
DCF Advisers, LLC 25,700$9,575,3105.86%
Artia Global Partners LP 36,404$13,563,4025.01%
Bellevue Group AG 886,928$330,451,6344.80%
Fairmount Funds Management LLC 73,526$27,394,3174.71%
Eagle Health Investments LP 64,400$23,994,1524.67%
Decheng Capital Management III (Cayman), LLC 27,429$10,219,4974.12%
RTW INVESTMENTS, LP 482,195$179,656,2133.74%
View complete list of ARGENX SE shareholders